Literature DB >> 12738645

Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.

F Roodbari1, M H Roustai, A Mostafaie, H Soleimanjdahi, R Sarrami Foroshani, F Sabahi.   

Abstract

Measles is a highly contagious respiratory virus infection, with typical clinical symptoms including maculopapular rash, fever, cough, coryza, and conjunctivitis. Despite implementation of widespread vaccination programs throughout the world, the rates of global morbidity and mortality are still considerable. This study was performed to design a reliable indirect enzyme-linked immunosorbent assay (ELISA) to measure measles-specific immunoglobulin M (IgM). First, human IgM was purified, and then an anti-IgM antibody was produced in rabbits and purified in a multistep process. The rabbit IgG against human IgM was conjugated with peroxidase. Measles virus-infected Vero cells produced viral antigen. One hundred serum samples from infants of 9 to 18 months of age, mostly vaccinated, were evaluated for determining the presence of specific IgM antibodies against measles virus. The samples were also evaluated for neutralizing antibodies against measles virus by a microneutralization test (MNT). By comparing the results of the ELISA with those of MNT, it was demonstrated that ELISA had a sensitivity and specificity of 100 and 92%, respectively. On the other hand, when the results obtained by our ELISA system were compared with those of an imported measles virus IgM ELISA kit (EIAgen; Adaltis Italia SPa, Bologna, Italy), a high level of agreement was shown (k = 0.926).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738645      PMCID: PMC154957          DOI: 10.1128/cdli.10.3.439-442.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles.

Authors:  S Ratnam; G Tipples; C Head; M Fauvel; M Fearon; B J Ward
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-06-13

5.  Laboratory diagnosis of measles infection and monitoring of measles immunization: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

6.  Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum.

Authors:  H S el Mubarak; M W Van De Bildt; O A Mustafa; H W Vos; M M Mukhtar; J Groen; A M el Hassan; H G Niesters; S A Ibrahim; E E Zijlstra; T F Wild; A D Osterhaus; R L De Swart
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay.

Authors:  D R Mayo; T Brennan; D P Cormier; J Hadler; P Lamb
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 8.  Pathogenesis of measles virus infection: an hypothesis for altered immune responses.

Authors:  D E Griffin; B J Ward; L M Esolen
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

9.  The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure.

Authors:  M M Agócs; L E Markowitz; I Straub; I Dömök
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

Review 10.  The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine.

Authors:  L E Markowitz; P Nieburg
Journal:  Rev Infect Dis       Date:  1991 May-Jun
View more
  1 in total

Review 1.  OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Authors:  Nicola Cotugno; Alessandra Ruggiero; Veronica Santilli; Emma Concetta Manno; Salvatore Rocca; Sonia Zicari; Donato Amodio; Manuela Colucci; Paolo Rossi; Ofer Levy; Federico Martinon-Torres; Andrew J Pollard; Paolo Palma
Journal:  J Immunol Res       Date:  2019-04-28       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.